A Massachusetts-based biotech company is stealing the show so far during Tuesday’s premarket hours after it was announced that it has entered into an exclusive license and...

To read the full story on AllPennyStocks.com, click here.

C4 Therapeutics (NASDAQ:CCCC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos C4 Therapeutics.
C4 Therapeutics (NASDAQ:CCCC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos C4 Therapeutics.